I think the primary outcome for Tripp is 16 week local disease control. So the last patient might be enrolled in May which equates with current progress. I don’t think analysis will take much longer.
I think that Pancosil date is wrong. They only have 4 patients to go and it’s essentially an open access safety trial. So results announced soon after.
And there’s an option exercise in June for a large amount.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
-0.015(1.30%) |
Mkt cap ! $21.46M | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.16 | $1.14 | $32.51K | 28.26K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 14293 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 8971 | 2 |
View Market Depth
| Last trade - 15.59pm 28/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |